Skip to content

A verification study of elevation of postprandial blood glucose level

A verification study of elevation of postprandial blood glucose level: an open-label study - A verification study of elevation of postprandial blood glucose level

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000053958
Enrollment
20
Registered
2024-03-25
Start date
2024-03-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese

Interventions

Duration: Single ingestion (21 types of test foods) Consumption of the test foods (order 1) Duration: Single ingestion (21 types of test foods) Consumption of the test foods (order 2) Duration:

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Medical Corporation Seishinkai, Takara Clinic Nerima Medical Association, Minami-machi Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Men or women 3. Individuals aged 18 or more and less than 65 4. Individuals whose BMI are 18.5 kg/m2 or more and less than 30 kg/m2 5. Healthy individuals

Exclusion criteria

Exclusion criteria: 1. Individuals who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Individuals who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Individuals who are currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, gastrointestinal disorder, or any other chronic diseases 4. Individuals who usually drink to excess (average of more than about 20 g/day as absolute alcohol intake) {500 mL: a medium bottle of beer or about 1.5 cans of canned chu-hi, 180 mL: 1 go of sake or about 1.5 glasses of wine, 90 mL: half-go with shochu, 60 mL: a glass of whiskey brandy (double)} 5. Individuals who are a smoker 6. Individuals who have irregular sleeping time or habit due to work such as a late-night shift 7. Individuals who have irregular lifestyles 8. Individuals who are taking "Foods for Specified Health Uses" or "Foods with Functional Claims" 9. Individuals who are taking or using medications (including herbal medicines) and supplements 10. Individuals who are allergic to medicines and/or the test product related products (particularly, eggs, wheat, buckwheat, milk ingredients, pork, chicken, beef, peanuts, soybeans, squid, shrimp, mackerel, salmon, sesame, apple, peach, and gelatin) 11. Individuals who are pregnant, lactating, or planning to become pregnant during this study 12. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate another study during this study 13. Individuals who are judged as ineligible to participate in this study by the physician

Design outcomes

Primary

MeasureTime frame
1. The incremental area under the curve (IAUC) of the blood glucose level

Secondary

MeasureTime frame
1. The maximum blood concentration (Cmax) of glucose, the measured values of the blood glucose level at each assessment point 2. The IAUC of visual analog scale (VAS), the measured values of VAS at each assessment point

Countries

Japan

Contacts

Public ContactNaoko Suzuki

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026